4
Changes in Ownership
ELITE PHARMACEUTICALS INC /NV/ Filed Acc 0000930413-05-000396
Director sold 392,109 shares at an average $4.28 ($1,679,830)
From the SEC's structured data for this filing
Trades in this filing
MOORE JOHN A · Director
Table I: Non-derivative
13 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2005-01-24 | Sale : show line 1 in the form | −10,000 | $4.14 | $41,400 | 53,000 | D |
| 2005-01-21 | Sale : show line 2 in the form | −25,000 | $4.27 | $106,743 | 53,000 | D |
| 2005-01-21 | Sale : show line 3 in the form | −25,000 | $4.31 | $107,633 | 53,000 | D |
| 2005-01-21 | Sale : show line 4 in the form | −32,109 | $4.35 | $139,674 | 53,000 | D |
| 2005-01-21 | Sale : show line 5 in the form | −50,000 | $4.32 | $216,000 | 53,000 | D |
| 2005-01-21 | Sale : show line 6 in the form | −125,000 | $4.30 | $537,500 | 53,000 | D |
| 2005-01-21 | Sale : show line 7 in the form | −25,000 | $4.27 | $106,750 | 53,000 | D |
| 2005-01-21 | Sale : show line 8 in the form | −40,000 | $4.25 | $170,000 | 53,000 | D |
| Open-market sales · 392,109 sh · avg $4.28 · $1,679,830 | ||||||
Loading xslF345X02/c35236_ex.xml…